Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa

Philipp M Lepper1, Eberhard Grusa, Helga Reichl

  • 1Section of Hospital Hygiene, Department of Medical Microbiology and Hygiene, Ulm University Hospital, Germany.

Insights

Hospital antibiotic policies significantly impact bacterial resistance. This study found imipenem use strongly correlated with increased Pseudomonas aeruginosa resistance, highlighting the need for balanced antibiotic stewardship to maintain microbial sensitivity patterns.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Hospital antibiotic prescription policies are widely believed to influence bacterial resistance rates.
  • However, robust statistical data directly linking policies to resistance, particularly for specific pathogens like Pseudomonas aeruginosa, remains limited.

Purpose of the Study:

  • To statistically evaluate the impact of antibiotic consumption on resistance rates of Pseudomonas aeruginosa.
  • To identify specific antibiotic agents whose usage patterns correlate with resistance development in a community hospital setting.

Main Methods:

  • A 3-year observational study (1997-2000) in a 600-bed hospital.
  • Monitored monthly consumption of beta-lactam and antipseudomonal antibiotics.
  • Assessed monthly P. aeruginosa isolations and recorded resistance rates.
  • Utilized partial correlation coefficients to analyze associations between antibiotic consumption and resistance, controlling for seasonality and patient transfers.

Main Results:

  • Imipenem consumption varied significantly, while other antipseudomonal agents remained stable, except for piperacillin-tazobactam.
  • P. aeruginosa resistance rates to imipenem, piperacillin-tazobactam, and ceftazidime showed a temporal correlation with imipenem prescription rates.
  • Imipenem consumption was identified as the primary driver for both carbapenem and beta-lactam resistance in endemic P. aeruginosa.

Conclusions:

  • Increased imipenem usage was directly associated with significant rises in P. aeruginosa resistance.
  • Hospital antibiotic policies that judiciously balance the use of different antibiotic classes are crucial for preserving microbial sensitivity patterns.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...